Li Haiqing, Hong Wei, Zeng Zixiong, Gong Shan, Wu Fan, Wang Zihui, Tian Heshen, Cheng Juan, Sun Ruiting, Gao Mi, Liang Chunxiao, Cao Weitao, Hu Guoping, Li Yuqun, Wei Liping, Zhou Yumin, Ran Pixin
Department of Respiratory Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
State Key Laboratory of Respiratory Disease, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Front Med (Lausanne). 2022 Mar 14;9:811975. doi: 10.3389/fmed.2022.811975. eCollection 2022.
Accumulating evidence suggests that oxidative stress is involved in the development of chronic obstructive pulmonary disease (COPD) and its progression. Activity of extracellular superoxide dismutase (ecSOD), the only extracellular enzyme eliminating superoxide radicals, has been reported to decline in acute exacerbations of COPD (AECOPD). However, the association between serum ecSOD activity and 1-year all-cause mortality in AECOPD patients remains unclear. The objective of our study was to explore the usefulness of ecSOD activity on admission in AECOPD as an objective predictor for 1-year all-cause mortality.
We measured serum ecSOD activity in AECOPD patients on admission in a prospective cohort study. We also recorded their laboratory and clinical data. Multivariate Cox regression was used to analyze the association between ecSOD activity and the risk of 1-year all-cause mortality. Restricted cubic spline curves were used to visualize the relationship between ecSOD activity and the hazard ratio of 1-year all-cause mortality.
A total of 367 patients were followed up for 1 year, and 29 patients died during a 1-year follow-up period. Compared with survivors, the non-survivors were older (79.52 ± 8.39 vs. 74.38 ± 9.34 years old, = 0.004) and had increased levels of tobacco consumption (47.07 ± 41.67 vs. 33.83 ± 31.79 pack-years, = 0.037). Having an ecSOD activity ≤ 98.8 U/ml was an independent risk factor of 1-year all-cause mortality after adjustment for baseline differences, clinical variables and comorbidities [hazard ratio = 5.51, 95% confidence interval (CI): 2.35-12.95, < 0.001].
Lower serum ecSOD activity was a strong and independent predictor of 1-year all-cause mortality in AECOPD patients.
越来越多的证据表明,氧化应激参与慢性阻塞性肺疾病(COPD)的发生发展及其进程。据报道,在慢性阻塞性肺疾病急性加重期(AECOPD),细胞外超氧化物歧化酶(ecSOD)作为唯一一种清除超氧阴离子自由基的细胞外酶,其活性会下降。然而,AECOPD患者血清ecSOD活性与1年全因死亡率之间的关联仍不明确。我们研究的目的是探讨AECOPD患者入院时ecSOD活性作为1年全因死亡率客观预测指标的有效性。
在一项前瞻性队列研究中,我们测量了AECOPD患者入院时的血清ecSOD活性。我们还记录了他们的实验室和临床数据。采用多因素Cox回归分析ecSOD活性与1年全因死亡风险之间的关联。使用受限立方样条曲线来直观呈现ecSOD活性与1年全因死亡率风险比之间的关系。
共有367例患者接受了1年的随访,其中29例患者在1年随访期内死亡。与幸存者相比,非幸存者年龄更大(79.52±8.39岁 vs. 74.38±9.34岁,P = 0.004),且吸烟量增加(47.07±41.67包年 vs. 33.83±31.79包年,P = 0.037)。在对基线差异、临床变量和合并症进行调整后,ecSOD活性≤98.8 U/ml是1年全因死亡率的独立危险因素[风险比 = 5.51,95%置信区间(CI):2.35 - 12.95,P < 0.001]。
较低的血清ecSOD活性是AECOPD患者1年全因死亡率的强有力独立预测指标。